PRTN3 and arthritic joint disease: SC ACPA levels were significantly increased in baseline samples from individuals subsequently progressing to arthritis (median 62 AU/ml, IQR 13–125) compared to individuals remaining arthritis-free during follow up (median 40 AU/ml, IQR 13–67; p < 0.001) (Fig. 1A).